Prudential Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.4M Buy
308,355
+165,013
+115% +$10.4M 0.03% 415
2025
Q1
$9.1M Sell
143,342
-740
-0.5% -$47K 0.01% 628
2024
Q4
$9.43M Buy
144,082
+81,887
+132% +$5.36M 0.01% 632
2024
Q3
$4.37M Buy
62,195
+43,429
+231% +$3.05M 0.01% 1047
2024
Q2
$1.55M Sell
18,766
-25,868
-58% -$2.13M ﹤0.01% 1574
2024
Q1
$3.9M Buy
44,634
+1,939
+5% +$169K 0.01% 1062
2023
Q4
$4.12M Sell
42,695
-34,890
-45% -$3.36M 0.01% 1033
2023
Q3
$6.92M Buy
77,585
+12,819
+20% +$1.14M 0.01% 776
2023
Q2
$5.61M Sell
64,766
-217,790
-77% -$18.9M 0.01% 843
2023
Q1
$27.5M Buy
282,556
+141,579
+100% +$13.8M 0.04% 368
2022
Q4
$14.6M Buy
140,977
+47,131
+50% +$4.88M 0.02% 501
2022
Q3
$7.96M Sell
93,846
-31,206
-25% -$2.65M 0.01% 721
2022
Q2
$10.4M Buy
125,052
+37,469
+43% +$3.12M 0.02% 651
2022
Q1
$6.75M Buy
87,583
+22,977
+36% +$1.77M 0.01% 844
2021
Q4
$5.71M Buy
64,606
+54,273
+525% +$4.8M 0.01% 953
2021
Q3
$804K Sell
10,333
-295
-3% -$23K ﹤0.01% 1932
2021
Q2
$887K Sell
10,628
-231
-2% -$19.3K ﹤0.01% 1887
2021
Q1
$820K Sell
10,859
-42,192
-80% -$3.19M ﹤0.01% 1939
2020
Q4
$4.65M Sell
53,051
-3,325
-6% -$292K 0.01% 1031
2020
Q3
$4.29M Sell
56,376
-6,120
-10% -$466K 0.01% 991
2020
Q2
$7.71M Sell
62,496
-19,759
-24% -$2.44M 0.01% 787
2020
Q1
$6.95M Sell
82,255
-29,148
-26% -$2.46M 0.02% 790
2019
Q4
$9.42M Buy
111,403
+6,135
+6% +$519K 0.01% 883
2019
Q3
$7.18M Buy
105,268
+1,392
+1% +$94.9K 0.01% 960
2019
Q2
$8.9M Buy
103,876
+527
+0.5% +$45.1K 0.01% 887
2019
Q1
$9.18M Sell
103,349
-9,254
-8% -$822K 0.02% 878
2018
Q4
$9.44M Sell
112,603
-16,939
-13% -$1.42M 0.02% 838
2018
Q3
$12.6M Sell
129,542
-30,206
-19% -$2.93M 0.02% 822
2018
Q2
$15M Sell
159,748
-10,552
-6% -$994K 0.02% 763
2018
Q1
$13.8M Buy
170,300
+11,600
+7% +$940K 0.02% 767
2017
Q4
$14.3M Hold
158,700
0.02% 773
2017
Q3
$14.8M Buy
158,700
+13,530
+9% +$1.26M 0.02% 749
2017
Q2
$13.2M Buy
145,170
+4,026
+3% +$366K 0.02% 783
2017
Q1
$12.4M Buy
141,144
+7,699
+6% +$676K 0.02% 789
2016
Q4
$11.1M Buy
133,445
+2,700
+2% +$224K 0.02% 826
2016
Q3
$12.1M Sell
130,745
-11,425
-8% -$1.06M 0.02% 754
2016
Q2
$11.1M Buy
142,170
+600
+0.4% +$46.7K 0.02% 780
2016
Q1
$11.7M Buy
141,570
+33,700
+31% +$2.78M 0.02% 754
2015
Q4
$11.3M Buy
107,870
+43,500
+68% +$4.56M 0.02% 747
2015
Q3
$6.78M Buy
64,370
+56,137
+682% +$5.91M 0.01% 894
2015
Q2
$1.13M Buy
8,233
+130
+2% +$17.8K ﹤0.01% 1773
2015
Q1
$1.01M Sell
8,103
-110
-1% -$13.7K ﹤0.01% 1819
2014
Q4
$742K Sell
8,213
-2,940
-26% -$266K ﹤0.01% 1834
2014
Q3
$805K Sell
11,153
-7,406
-40% -$535K ﹤0.01% 1794
2014
Q2
$1.16M Buy
18,559
+7,206
+63% +$448K ﹤0.01% 1770
2014
Q1
$774K Sell
11,353
-100
-0.9% -$6.82K ﹤0.01% 1835
2013
Q4
$805K Sell
11,453
-1,700
-13% -$119K ﹤0.01% 1827
2013
Q3
$950K Sell
13,153
-150
-1% -$10.8K ﹤0.01% 1753
2013
Q2
$742K Buy
+13,303
New +$742K ﹤0.01% 1824